berberine has been researched along with Adenocarcinoma in 12 studies
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Berberine is an alkaloid isolated from the Chinese herbal medicine Huanglian, and has long been used as an antibiotic." | 5.40 | Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo. ( Cai, Y; Huang, P; Jiang, W; Luo, R; Shi, Y; Sun, Y; Xia, Q, 2014) |
| " Here, we show that treatment of pancreatic ductal adenocarcinoma (PDAC) cells (PANC-1, MiaPaCa-2) with the isoquinoline alkaloid berberine (0." | 3.80 | Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells. ( Eibl, G; Ming, M; Rozengurt, E; Sinnett-Smith, J; Soares, HP; Wang, J; Young, SH, 2014) |
| "Berberine was used to determine loss of viable cells and inhibition of arylamine Nacetyltransferase (NAT) activity in a human colon tumor (adenocarcinoma) cell line." | 3.70 | Effects of berberine on arylamine N-acetyltransferase activity in human colon tumor cells. ( Chang, HL; Chen, GW; Chung, JG; Lin, JG; Wang, TF; Wu, LT, 1999) |
| "KRas is frequently mutated in pancreatic cancers." | 1.62 | GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals. ( Abrams, SL; Akula, SM; Candido, S; Cervello, M; Cocco, L; Duda, P; Falzone, L; Gizak, A; Libra, M; Martelli, AM; McCubrey, JA; Meher, AK; Montalto, G; Rakus, D; Ratti, S; Ruvolo, P; Steelman, LS, 2021) |
| "Berberine is an alkaloid isolated from the Chinese herbal medicine Huanglian, and has long been used as an antibiotic." | 1.40 | Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo. ( Cai, Y; Huang, P; Jiang, W; Luo, R; Shi, Y; Sun, Y; Xia, Q, 2014) |
| "Colon cancer is one of the most common malignancies, mainly initiated by the abnormal activation of Wnt/β-catenin signaling." | 1.38 | Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/β-catenin signaling. ( He, B; Liu, Y; Mu, Y; Wu, K; Yang, Q; Zhou, L; Zhou, Q, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Othman, MS | 1 |
| Al-Bagawi, AH | 1 |
| Obeidat, ST | 1 |
| Fareid, MA | 1 |
| Habotta, OA | 1 |
| Moneim, AEA | 1 |
| Izadparast, F | 1 |
| Riahi-Zajani, B | 1 |
| Yarmohammadi, F | 1 |
| Hayes, AW | 1 |
| Karimi, G | 1 |
| Abrams, SL | 1 |
| Akula, SM | 1 |
| Meher, AK | 1 |
| Steelman, LS | 1 |
| Gizak, A | 1 |
| Duda, P | 1 |
| Rakus, D | 1 |
| Martelli, AM | 1 |
| Ratti, S | 1 |
| Cocco, L | 1 |
| Montalto, G | 1 |
| Cervello, M | 1 |
| Ruvolo, P | 1 |
| Libra, M | 1 |
| Falzone, L | 1 |
| Candido, S | 1 |
| McCubrey, JA | 1 |
| Kabary, DM | 1 |
| Helmy, MW | 1 |
| Abdelfattah, EA | 1 |
| Fang, JY | 1 |
| Elkhodairy, KA | 1 |
| Elzoghby, AO | 1 |
| Cai, Y | 1 |
| Xia, Q | 1 |
| Luo, R | 1 |
| Huang, P | 1 |
| Sun, Y | 1 |
| Shi, Y | 1 |
| Jiang, W | 1 |
| Zheng, F | 1 |
| Tang, Q | 1 |
| Wu, J | 1 |
| Zhao, S | 1 |
| Liang, Z | 1 |
| Li, L | 1 |
| Wu, W | 1 |
| Hann, S | 1 |
| Ming, M | 1 |
| Sinnett-Smith, J | 1 |
| Wang, J | 1 |
| Soares, HP | 1 |
| Young, SH | 1 |
| Eibl, G | 1 |
| Rozengurt, E | 1 |
| Muralimanoharan, SB | 1 |
| Kunnumakkara, AB | 1 |
| Shylesh, B | 1 |
| Kulkarni, KH | 1 |
| Haiyan, X | 1 |
| Ming, H | 1 |
| Aggarwal, BB | 1 |
| Rita, G | 1 |
| Kumar, AP | 1 |
| Kim, S | 1 |
| Han, J | 1 |
| Lee, SK | 1 |
| Choi, MY | 1 |
| Kim, J | 1 |
| Lee, J | 1 |
| Jung, SP | 1 |
| Kim, JS | 1 |
| Kim, JH | 1 |
| Choe, JH | 1 |
| Lee, JE | 1 |
| Nam, SJ | 1 |
| Wu, K | 1 |
| Yang, Q | 1 |
| Mu, Y | 1 |
| Zhou, L | 1 |
| Liu, Y | 1 |
| Zhou, Q | 1 |
| He, B | 1 |
| Lin, JG | 1 |
| Chung, JG | 1 |
| Wu, LT | 1 |
| Chen, GW | 1 |
| Chang, HL | 1 |
| Wang, TF | 1 |
| Iizuka, N | 1 |
| Hazama, S | 1 |
| Yoshimura, K | 1 |
| Yoshino, S | 1 |
| Tangoku, A | 1 |
| Miyamoto, K | 1 |
| Okita, K | 1 |
| Oka, M | 1 |
1 review available for berberine and Adenocarcinoma
| Article | Year |
|---|---|
Protective effect of berberine against LPS-induced injury in the intestine: a review.
Topics: Adenocarcinoma; Animals; Berberine; Caco-2 Cells; Colonic Neoplasms; Cyclooxygenase 2; Humans; Intes | 2022 |
11 other studies available for berberine and Adenocarcinoma
| Article | Year |
|---|---|
Antitumor Activity of Zinc Nanoparticles Synthesized with Berberine on Human Epithelial Colorectal Adenocarcinoma (Caco-2) Cells through Acting on Cox-2/NF-kB and p53 Pathways.
Topics: Adenocarcinoma; Animals; Apoptosis; bcl-2-Associated X Protein; Berberine; Caco-2 Cells; Caspase 3; | 2022 |
GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals.
Topics: Adenocarcinoma; Adenylate Kinase; Antineoplastic Agents; bcl-X Protein; Berberine; Biphenyl Compound | 2021 |
Inhalable multi-compartmental phospholipid enveloped lipid core nanocomposites for localized mTOR inhibitor/herbal combined therapy of lung carcinoma.
Topics: A549 Cells; Adenocarcinoma; Administration, Inhalation; Animals; Antineoplastic Combined Chemotherap | 2018 |
Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Pro | 2014 |
p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Berberine; Cell Line, Tumo | 2014 |
Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells.
Topics: Acetyl-CoA Carboxylase; Adenocarcinoma; AMP-Activated Protein Kinases; Animals; Berberine; Carcinoma | 2014 |
Butanol fraction containing berberine or related compound from nexrutine inhibits NFkappaB signaling and induces apoptosis in prostate cancer cells.
Topics: Adenocarcinoma; Apoptosis; Berberine; Butanols; Cell Line, Tumor; Cell Proliferation; Humans; I-kapp | 2009 |
Berberine suppresses the TPA-induced MMP-1 and MMP-9 expressions through the inhibition of PKC-α in breast cancer cells.
Topics: Adenocarcinoma; Berberine; Breast Neoplasms; Carcinogens; Cell Line, Tumor; Cell Movement; Dose-Resp | 2012 |
Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/β-catenin signaling.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Berb | 2012 |
Effects of berberine on arylamine N-acetyltransferase activity in human colon tumor cells.
Topics: 4-Aminobenzoic Acid; Adenocarcinoma; Aflatoxins; Arylamine N-Acetyltransferase; Berberine; Carcinoge | 1999 |
Anticachectic effects of the natural herb Coptidis rhizoma and berberine on mice bearing colon 26/clone 20 adenocarcinoma.
Topics: Adenocarcinoma; Adipose Tissue; Animals; Berberine; Cachexia; Colonic Neoplasms; Coptis chinensis; D | 2002 |